Fleury, F.
Publications
P157
Int. J. Mol. Sci. 2016, 17, E703.
Rapid Diminution in the Level and Activity of DNA-Dependent Protein Kinase in Cancer Cells by a Reactive Nitro-Benzoxadiazole Compound.
Silva, V. A.
Lafont, F.
Benhelli-Mokrani, H.
Breton, M. L.
Hulin, P.
Chabot, T.
Paris, F.
Sakanyan, V.
Fleury, F.
doi: 10.3390/ijms17050703.
P126
Sci. Rep. 2014, 4:3977.
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.
Sakanyan, V.
Angelini, M.
Le Béchec, M.
Lecocq, M.-F.
Benaiteau, F.
Rousseau, B.
Gyulkhandanyan, A.
Gyulkhandanyan, L.
Logé, C.
Reiter, E.
Roussakis, C.
Fleury, F.
doi: 10.1038/srep03977.
Autres publications scientifiques
PS02
Marine Drugs. 2021, 378.
Untargeted metabolomics approach for the discovery of environment-related pyran-2-ones chemodiversity in a marine-sourced Penicillium restrictum.